Antimicrobial gelatin-based films with cinnamaldehyde and ZnO nanoparticles for sustainable food packaging.

Cinnamaldehyde (CIN), a harmless bioactive chemical, is used in bio-based packaging films for its antibacterial and antioxidant properties. However, high amounts can change food flavor and odor. Thus, ZnO nanoparticles (NPs) as a supplementary antimicrobial agent are added to gelatin film with CIN. The CIN/ZnO interactions are the main topic of this investigation. FTIR-Attenuated Total Reflection (ATR), X-ray diffraction (XRD), and scanning electron microscopy (SEM) were utilized to investigate CIN/ZnO@gelatin films. Transmission electron microscope (TEM) images revealed nanospheres morphology of ZnO NPs, with particle sizes ranging from 12 to 22 nm. ZnO NPs integration increased the overall activation energy of CIN/ZnO@gelatin by 11.94%. The incorporation of ZnO NPs into the CIN@gelatin film significantly reduced water vapour permeability (WVP) of the CIN/ZnO@gelatin film by 12.07% and the oxygen permeability (OP) by 86.86%. The water sorption isotherms of CIN/ZnO@gelatin were described using Guggenheim-Anderson-de Boer (GAB) model. The incorporation of ZnO NPs into the CIN@gelatin film reduced monolayer moisture content (M0) by 35.79% and significantly decreased the solubility of CIN/ZnO@gelatin by 15.15%. The inclusion of ZnO into CIN@gelatin film significantly decreased tensile strength of CIN/ZnO@gelatin by 13.32% and Young`s modulus by 18.33% and enhanced elongation at break by 11.27%. The incorporation of ZnO NPs into the CIN@gelatin film caused a significant decrease of antioxidant activity of CIN/ZnO@gelatin film by 9.09%. The most susceptible organisms to the CIN/ZnO@gelatin film included Candida albicans, Helicobacter pylori, and Micrococcus leutus. The inhibition zone produced by the CIN/ZnO@gelatin film versus Micrococcus leutus was 25.0 mm, which was comparable to the inhibition zone created by antibacterial gentamicin (23.33 mm) and cell viability assessment revealed that ZnO/CIN@gelatin (96.8 ± 0.1%) showed great performance as potent biocompatible active packaging material.

Fabrication and evaluation of antimicrobial cellulose/Arabic gum hydrogels as potential drug delivery vehicle.

This article aims to assess the highly potent antimicrobial hydrogels composed of cellulose and Arabic gum containing sulfadiazine drug (sulfadiazine-loaded Cel/AG) as drug-targeting carriers. ATR-IR, SEM/ EDS, XRD, and XPS methods were used to investigate the hydrogel. The highest water absorption % was 489.93 ± 4.5 at pH 7.4. Pseudo-second order and Fickian diffusion govern the swelling behavior. The maximal sulfadiazine loading percent was 82.291 ± 74. The in-vitro drug release exhibited significant responses in physiologically simulated pH values. The maximum cumulative release percent was 66.42 ± 0.6 % at pH 7.4. The drug release is predicted by the first order and Korsmeyer-Peppas models. The first diffusion coefficient was (Di = 9.207 ± 47 × 10-3 cm2/h) and the late one was (DL = 5.64 ± 9.0 × 10-2 cm2/h) at pH 7.4. That hydrogel is well-thought-out a potential drug delivery vehicle. The thermal stability of the Cel/AG hydrogel drug carrier has been enhanced by the incorporation of sulfadiazine which is evidenced by increasing the total activation approximately two-fold. The total activation energy of Cel/AG and sulfadiazine-loaded Cel/AG hydrogels were -0.07362 and -0.2092 J/mol. The sulfadiazine medication's inhibitory effect was markedly enhanced when it was incorporated into the Cel/AG hydrogel films.

Physically-crosslinked hydroxyethyl cellulose-g-poly (acrylic acid-co-acrylamide)-Fe3+/silver nanoparticles for water disinfection and enhanced adsorption of basic methylene blue dye.

In this study, we report the development of physically cross-linked hydroxyethyl cellulose grafted polyacrylic acid-co-polyacrylamide/silver nanocomposite [Ag@HEC-g-P(AA-co-AM)-Fe3+] possesses excellent antimicrobial and enhanced MB adsorption. A green in-situ reduction process was used to prepare silver nanoparticles. UV-Vis spectroscopy, TEM, ATR-IR, XRD, SEM-EDS were used to analyze the green produced silver nanoparticles and Ag@HEC-g-P(AA-co-AM)-Fe3+. The swelling ratio of Ag@HEC-g-P(AA-co-AM)-Fe3+ is dependent on AgNPs content and pH. The swelling kinetics fitted with Pseudo-second order. The cumulative release#% of AgNPs was 29.63 ± 1.7%, respectively up to 10 h and its kinetics obey Korsmeyer-Peppas model. The grafting to HEC and incorporation of AgNPs into HEC-g-P(AA-co-AM)-Fe3+ enhances the thermal stabilities and increases total activation energies from 19,122.2 to 66,287.1 KJ mol. Ag@HEC-g-P(AA-co-AM)-Fe3+ has powerful antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, Micrococcus leutus, Staphyllococus aureus. The maximum adsorption capacity of MB was 133.38 ± 1.25 mg/g at nanocomposite concentration (300 mg/L), pH (9.0), and MB concentration (5 mg/L). To anticipate the adsorption mechanism, Pseudo-first and second-order models, as well as three isotherm models (Langmuir, Freundlich, and Temkin) were used to model adsorption kinetics. The nonlinear Langmuir models and second-order kinetics were the most appropriate.

Biological and Mechanical Properties of Denture Base Material as a Vehicle for Novel Hydroxyapatite Nanoparticles Loaded with Drug.

Purpose: This study aimed to evaluate the biological and mechanical properties of the poly(methyl methacrylate) (PMMA) denture base material as a vehicle incorporating novel hydroxyapatite nanoparticles (HA-NP) loaded with metronidazole (MZ) drug. Methods: HA-NP was prepared via wet-chemical-method, characterized by XRD, SEM/EDX, TEM, Fourier-transform infrared spectroscopy (FTIR), as well as the measurement of surface area and pore-size distribution. Four drug delivery formulas were prepared in the form of discs (10 x 2 mm) as follows: F1 (MZ/ HA-NP/PMMA), F2 (HA-NP/ PMMA), F3 (control-PMMA) and F4 (MZ/PMMA). Characterization of all formulas was performed using differential scanning calorimetry (DSC) and FTIR. MZ release rate, antimicrobial properties against three oral pathogens, cytotoxicity (MTT assay) and surface micro-hardness were also assessed. Statistical analysis of data was performed using one-way ANOVA test (P < 0.05). Results: DSC thermograms showed compatibility among MZ, HA-NP and PMMA along with physical stability over 6 months storage period at room temperature. FTIR spectroscopy proved the absence of any possible chemical interaction with MZ. MZ-HA-NP/PMMA formula showed relatively better drug release compared to MZ-PMMA. Both formulas showed statistically significant antimicrobial potentials against two microbial strains. MTT demonstrated reduction in cell cytotoxicity after 96 hours with the least value for HA-NP. Surface micro-hardness revealed non-significant reduction compared with the control PMMA. Conclusion: A novel biocompatible drug nanocarrier (HA-NP) was developed and incorporated in PMMA denture base material as a vehicle to allow prolonged sustained drug release to manage oral infections.